ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Targeted immunotherapies to consider for B Cell non-hodgkin lymphoma
Expert Review of Precision Medicine and Drug Development
◽
10.1080/23808993.2021.1967142
◽
2021
◽
pp. 1-16
Author(s):
Esin C. Namoglu
◽
Mitchell E. Hughes
◽
Sunita D. Nasta
Keyword(s):
B Cell
◽
Hodgkin Lymphoma
◽
Non Hodgkin Lymphoma
Download Full-text
Related Documents
Cited By
References
B-cell non-Hodgkin lymphoma (B-NHL) in patients with chronic hepatitis C. A report of 5 cases
Zeitschrift für Gastroenterologie
◽
10.1055/s-0033-1347495
◽
2013
◽
Vol 51
(05)
◽
Author(s):
I Nagy
◽
A Pálvölgyi
◽
S Modok
◽
T Wittmann
Keyword(s):
Chronic Hepatitis
◽
Hepatitis C
◽
B Cell
◽
Hodgkin Lymphoma
◽
Chronic Hepatitis C
◽
Non Hodgkin Lymphoma
Download Full-text
B-Cell Non-Hodgkin Lymphoma
10.32388/91hm87
◽
2020
◽
Author(s):
Keyword(s):
B Cell
◽
Hodgkin Lymphoma
◽
Non Hodgkin Lymphoma
Download Full-text
Anti-Lipopolysaccharide Antibodies and Osmotic Resistance of Erythrocytes in Healthy Individuals and Patients with B-Cell Non-Hodgkin Lymphoma with Different Blood Groups
Mikrobiolohichnyi Zhurnal
◽
10.15407/microbiolj82.04.003
◽
2020
◽
Vol 82
(4)
◽
pp. 3-12
Author(s):
L.D. Varbanets
◽
◽
K.G. Garkava
◽
O.S. Brovarskaya
◽
T.V. Bulyhina
◽
...
Keyword(s):
B Cell
◽
Hodgkin Lymphoma
◽
Blood Groups
◽
Osmotic Resistance
◽
Healthy Individuals
◽
Non Hodgkin Lymphoma
◽
Osmotic Resistance Of Erythrocytes
Download Full-text
Copanlisib in Combination With Venetoclax in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.
Case Medical Research
◽
10.31525/ct1-nct03886649
◽
2019
◽
Author(s):
Keyword(s):
B Cell
◽
Hodgkin Lymphoma
◽
Non Hodgkin Lymphoma
Download Full-text
Acalabrutinib With Rituximab and Lenalidomide in Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Case Medical Research
◽
10.31525/ct1-nct04094142
◽
2019
◽
Author(s):
Keyword(s):
B Cell
◽
Hodgkin Lymphoma
◽
Non Hodgkin Lymphoma
Download Full-text
Phase II Trial of TisaGenlecleucel (Kymriah®) in Elderly Patients With First-Relapsed or Primary Refractory Agressive B-cell Non-Hodgkin Lymphoma
Case Medical Research
◽
10.31525/ct1-nct04161118
◽
2019
◽
Author(s):
Keyword(s):
Elderly Patients
◽
B Cell
◽
Hodgkin Lymphoma
◽
Phase Ii
◽
Phase Ii Trial
◽
Non Hodgkin Lymphoma
Download Full-text
Faculty Opinions recommendation of Serum-free light chain-a new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1072097.525084
◽
2007
◽
Author(s):
Emili Montserrat
Keyword(s):
Chronic Lymphocytic Leukemia
◽
B Cell
◽
Hodgkin Lymphoma
◽
Light Chain
◽
Free Light Chain
◽
Lymphocytic Leukemia
◽
Serum Free
◽
Serum Free Light Chain
◽
Non Hodgkin Lymphoma
Download Full-text
Faculty Opinions recommendation of IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.14265959.15778063
◽
2012
◽
Author(s):
Larry Kane
◽
Judong Lee
Keyword(s):
T Cell
◽
B Cell
◽
Hodgkin Lymphoma
◽
T Cell Exhaustion
◽
Cell Exhaustion
◽
Non Hodgkin Lymphoma
Download Full-text
Faculty Opinions recommendation of Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718499066.793521333
◽
2016
◽
Author(s):
Won Seog Kim
Keyword(s):
B Cell
◽
Hodgkin Lymphoma
◽
Non Hodgkin Lymphoma
◽
Treatment Naïve
◽
Phase 1B
Download Full-text
One Year of Maintenance Metronomic Cyclophosphamide, Methotreaxate & Celecoxib in High Risk Diffuse Large B Cell Non Hodgkin Lymphoma After Complete Response.
Research in Oncology
◽
10.21608/resoncol.2014.882
◽
2014
◽
Vol 10
(Issue 1-2)
◽
pp. 40-45
Author(s):
S. AlHassanin
◽
T. Hashem
◽
K. ElDin
◽
H. Kohail
◽
H. ElSheridy
◽
...
Keyword(s):
High Risk
◽
B Cell
◽
Hodgkin Lymphoma
◽
Complete Response
◽
Non Hodgkin Lymphoma
◽
One Year
◽
Metronomic Cyclophosphamide
◽
Large B Cell
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close